New weekly shot shows promise for shedding pounds in obesity trial
NCT ID NCT06712836
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 29 times
Summary
This study tests a new drug called MET097, given as a weekly shot, to help people with obesity or overweight lose weight. About 225 adults will receive either the drug or a placebo for 28 weeks. The main goal is to see how much weight they lose compared to those on placebo.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Anaheim Clinical Trials, LLC
Anaheim, California, 92801, United States
-
Research Centers of America
Hollywood, Florida, 92801, United States
Conditions
Explore the condition pages connected to this study.